6 Annual

th

Conference

regulatory
expectations
compliance
safety
patients

Pharmacovigilance
and Risk
Management
Strategies
27 – 29 January 2016 | Munich, Germany
www.fleming.events

Post Show Report

Conference In Numbers

10 3 19
Hours of Days Participating
Networking Countries

19 21 91
Speakers Hour Program Attendees

Top Speakers
Shelley Gandhi Waltraud Trabe Michael Ibara
Pharmacovigilance Director Head of Department Blood, Tissue & Head of Digital Healthcare
NDA Group Vigilance CDISC
Austrian Agency for Health and Food
Safety (AGES)

Kristina Strutt Sabine Poltermann Sara Gama

SVP Global Pharmacovigilance, EU QPPV Head of Drug Safety Project Excellence Group Head – Safety Processes and
Ipsen Novartis Aggregate Reporting
Novartis

Karen Pattenden Karsten Lollike Francoise Sillan

Sr Director Drug Safety and Public Health Corporate VP, QPPV QPPV, Head of QPPV office and
Gilead Sciences Novo Nordisk Pharmacovigilance Policy
Sanofi

Jens-Ulrich Stegmann Doris Irene Stenver Nour Zibian

VP, Head Clinical Safety and Chief Medical Officer, Member of the Sr. Safety Scientist
Pharmacovigilance PRAC UBC
GSK Danish Health and Medicine Authority

Tanja Peters Andrew Moore Dr. Simon Ingate

Global head of PV Intelligence, Deputy EU Senior Director Global Drug Safety, Head Principal Consultant - Safety Gauge
QPPV of QPPV and Alliance Office Product Manager
Boehringer Ingelheim Grunenthal Pope Woodhead & Associates Ltd

Top Presentations
Signal Detection Patient Safety is everybody’s business
by NDA Group by Ipsen

PSMF: Lessons Learned, Regulator’s Safety Exchange Agreements:

perspective Requirements
by AGES by Gilead Sciences

Pharmacovigilance in Africa a Pharmacovigilance Intelligence as a

continent with specific challenges to Global Function
ensure patient safety by Boehringer Ingelheim
by GSK

www.fleming.events Post Show Report

Highlights

Workshop on Workshop on Signal

Workshop on PSMF
Social Media in Detection and
Pharmacovigilance Quality Assurance of
PV Data Collected

Benefits of Most common findings

The most current and Red Flags in
the global
regulatory updates inspections
harmonization of PV
from PRAC
activities

Our Thank You

We would like to thank:
• our partners and sponsors for supporting us and the whole event,
• our speakers and advisors for contributing with their knowledge, experience and strategies, and
• our delegates, who were a great audience that enthusiastically proposed their ideas and boosted
discussions.
We were very delighted that you chose to attend the 6thAnnual Pharmacovigilance and Risk
Management Strategies Forum in Munich, Germany and we had the chance to meet you. We believe
that the event was beneficial for you in terms of both learning and networking.
I hope to see many of you at the Pharmacovigilance and Risk Management Strategies Forum again
and look forward to hearing your new findings and experience.

Lesly Solei
Conference Producer

regulatory
expectations
compliance
safety
patients

www.fleming.events Post Show Report

Participating Companies
 4C Pharma  Danish Health  Orphan Europe
Solutions and Medicines  Pfizer
 Abbot Agency
 Pharmasol
Laboratories  Drug Safety
 Pierre Fabre
 AGES Research Unit
Medicament
 Amgros I/S  Fishawack
 Pope Woodhead
Archimed
 Aspen Pharma & Associates
 Genesis Pharma
 AstraZeneca  Product Life
 Gilead Sciences
 Axon  Product Life
Neuroscience  Gilead Sciences Group
International
 Barrington James  Przedsiebiorstwo
 Grunenthal Farmaceutyczne
 Basilea
Pharmaceutica  GSK LEK- AM
 Bayer Pharma  Horizon Pharma  Sandoz
 INC Research International
 Bioclinica
 Ipsen  Sanofi
 Biogen
 Johnson and  Sanofi Pasteur
 Bionika
Pharmaceuticals Johnson  Springer
 Biotest  MorphoSys  UBC
 Boehringer  MundiPharma  UCB Biopharma
Ingelheim Research  UCB Pharma
 Boehringer  NDA Group  United
Ingelheim Israel  Novartis Therapeutics
 Bracco Imaging  Novartis Pharma  Université de
 C3i Healthcare  Novartis Poland Bordeaux
Connections  Novo Nordisk  Virbac
 CDISC  Novo Nordisk  Walmark
 Celgene R&D A/S
 Colgate-  Olainfarm
Palmolive

Our Partners
Gold Sponsors:

Silver Sponsors:

Bronze Sponsors:

www.fleming.events Post Show Report

 The Next
Annual
Pharmacovigilance
7 Annual

& Risk Management

Strategies
th

25 - 27 of January 2017, Amsterdam, Netherlands

For sponsorship opportunities: For media partnership opportunities:

Jenai Simmons Martina Hrabinska

Senior Business Development Manager Marketing Manager

Fleming. Fleming.
Budapest, Hungary Bratislava, Slovak Republic
T: +361 411 1840 T: +421 257 272 145
F: +361 411 1841 F: +421 255 644 490
E: jenai.simmons@fleming.events E: martina.hrabinska@fleming.events

ABOUT Fleming.

Fleming. connects great people, useful know-how and valuable opportunities.

With 12 years in the business and 300+ events organized annually, Fleming. has
grown to offer a portfolio of Conferences, Trainings, Exhibitions, Blended Learning
and Online Conferences. Present on five continents Fleming. has partnerships to
always stay one step ahead. More than 50,000 satisfied companies participating at
our events every year prove that Fleming. is the right partner.